Price Disclosure Act PDF Download

Author: United States. Congress. Senate. Committee on Commerce. Consumer Subcommittee
Publisher:
ISBN:
Category : Disclosure of information
Languages : en
Pages : 304

View

Book Description

Author:
Publisher:
ISBN:
Category : Labor laws and legislation
Languages : en
Pages : 32

View

Book Description

Author: United States. Congress. Senate. Committee on Commerce. Consumer Subcommittee
Publisher:
ISBN:
Category : Consumer protection
Languages : en
Pages : 316

View

Book Description

Author: United States. Congress. Senate. Commerce Committee
Publisher:
ISBN:
Category :
Languages : en
Pages : 312

View

Book Description

Author: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance
Publisher:
ISBN:
Category : Disclosure of information
Languages : en
Pages : 106

View

Book Description

Author: American Bar Association. House of Delegates
Publisher: American Bar Association
ISBN: 9781590318737
Category : Law
Languages : en
Pages : 216

View

Book Description
The Model Rules of Professional Conduct provides an up-to-date resource for information on legal ethics. Federal, state and local courts in all jurisdictions look to the Rules for guidance in solving lawyer malpractice cases, disciplinary actions, disqualification issues, sanctions questions and much more. In this volume, black-letter Rules of Professional Conduct are followed by numbered Comments that explain each Rule's purpose and provide suggestions for its practical application. The Rules will help you identify proper conduct in a variety of given situations, review those instances where discretionary action is possible, and define the nature of the relationship between you and your clients, colleagues and the courts.

Author: Felix C. Larsen
Publisher: Nova Snova
ISBN: 9781536179040
Category :
Languages : en
Pages : 340

View

Book Description
The 340B Drug Pricing Program (340B Program) and the Medicaid Drug Rebate Program require manufacturers to provide discounts on outpatient drugs in order to have their drugs covered by Medicaid. These discounts take the form of reduced sales prices for covered entities participating in the 340B Program--eligible hospitals and federal grantees--and rebates on drugs dispensed to Medicaid beneficiaries, shared by states and the federal government. This book looks at important issues pertaining to the 340B Drug Pricing Program.

Author: Barry Leonard
Publisher: DIANE Publishing
ISBN: 0756702534
Category :
Languages : en
Pages : 118

View

Book Description
Report by the Federal Trade Commission (FTC) on the information that businesses should consider as they develop online advertisements to ensure that they comply with the law. The same consumer protection laws that apply to commercial activities in other media apply online. The FTC Act's prohibition on unfair or deceptive acts or practicesÓ encompasses Internet advertisements, marketing & sales. It discusses: (1) the requirement for clear & conspicuous disclosures to prevent an advertisement from being misleading, to ensure that consumers receive material information about the terms of a transaction; (2) ways that advertisers can make such disclosures; & (3) FTC rules & guides that are adaptable to new technologies.

Author: United States
Publisher:
ISBN:
Category : Education, Higher
Languages : en
Pages : 432

View

Book Description

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235

View

Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.